Characterization of the human liver vasopressin receptor. Profound differences between human and rat vasopressin-receptor-mediated responses suggest only a minor role for vasopressin in regulating human hepatic function
- PMID: 2039469
- PMCID: PMC1151163
- DOI: 10.1042/bj2760189
Characterization of the human liver vasopressin receptor. Profound differences between human and rat vasopressin-receptor-mediated responses suggest only a minor role for vasopressin in regulating human hepatic function
Abstract
The [Arg8]vasopressin (AVP) receptor expressed by human hepatocytes was characterized, and compared with the rat hepatic V1a vasopressin receptor subtype. In addition to determining the pharmacological profile of the human receptor, the cellular responses to AVP were measured in human and rat hepatocytes by assaying glycogen phosphorylase alpha activity and DNA synthesis. Marked differences were observed between human and rat hepatocytes regarding vasopressin receptors and the intracellular consequences of stimulation by AVP. Data presented in this paper demonstrate the following, (i) Vasopressin V1a receptors are present in low abundance on human hepatocytes. (ii) Species differences exist between human and rat V1a receptors with respect to the affinity of some selective antagonists. (iii) AVP-stimulated glycogen phosphorylase a activation in human hepatocytes was approx. 5% of that observed in rat cells. (iv) In contrast with rat hepatocytes, DNA synthesis in human cells in culture was not stimulated by AVP. It is concluded that vasopressin plays only a minor role in the regulation of human hepatic function. Furthermore, conclusions drawn from observations made with AVP and its analogues on rat hepatic function cannot be directly extrapolated to the human situation.
Similar articles
-
Novel vasopressin receptor ligands.Biochem Soc Trans. 1991 Apr;19(2):87S. doi: 10.1042/bst019087s. Biochem Soc Trans. 1991. PMID: 1832402 No abstract available.
-
Regulation of ANG II and AVP receptors in isolated hepatocytes of pregnant rats.Am J Physiol. 1990 Apr;258(4 Pt 1):E597-605. doi: 10.1152/ajpendo.1990.258.4.E597. Am J Physiol. 1990. PMID: 2333959
-
Identification and characterization of arginine vasopressin receptors in the rat testis.Endocrinology. 1985 Jan;116(1):416-23. doi: 10.1210/endo-116-1-416. Endocrinology. 1985. PMID: 2981073
-
Molecular cloning and expression of rat V1a and V2 arginine vasopressin receptors.Regul Pept. 1993 Apr 29;45(1-2):53-9. doi: 10.1016/0167-0115(93)90182-8. Regul Pept. 1993. PMID: 8511367 Review.
-
Signal transduction of V1-vascular vasopressin receptors.Regul Pept. 1992 Mar 5;38(1):1-11. doi: 10.1016/0167-0115(92)90067-5. Regul Pept. 1992. PMID: 1533467 Review.
Cited by
-
Vasopressin: a novel target for the prevention and retardation of kidney disease?Nat Rev Nephrol. 2013 Apr;9(4):223-39. doi: 10.1038/nrneph.2013.22. Epub 2013 Feb 26. Nat Rev Nephrol. 2013. PMID: 23438973 Review.
-
The Efficacy and Safety of Tolvaptan in Patients with Hyponatremia: A Meta-Analysis of Randomized Controlled Trials.Clin Drug Investig. 2017 Apr;37(4):327-342. doi: 10.1007/s40261-016-0470-3. Clin Drug Investig. 2017. PMID: 27766511 Review.
-
Metabolic Functions of G Protein-Coupled Receptors in Hepatocytes-Potential Applications for Diabetes and NAFLD.Biomolecules. 2020 Oct 15;10(10):1445. doi: 10.3390/biom10101445. Biomolecules. 2020. PMID: 33076386 Free PMC article. Review.
-
The Interplay Between Pituitary Health and Diabetes Mellitus - The Need for 'Hypophyseo-Vigilance'.Eur Endocrinol. 2020 Apr;16(1):25-31. doi: 10.17925/EE.2020.16.1.25. Epub 2019 Oct 18. Eur Endocrinol. 2020. PMID: 32595766 Free PMC article. Review.
-
Biochemical and pharmacological properties of SR 49059, a new, potent, nonpeptide antagonist of rat and human vasopressin V1a receptors.J Clin Invest. 1993 Jul;92(1):224-31. doi: 10.1172/JCI116554. J Clin Invest. 1993. PMID: 8392086 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous